How do you pay?

How to pay the least

Ask for the cash price

Sogroya

Sogroya is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Sogroya’s cash price, and one or two other pharmacies too.
  2. Sogroya’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameSogroya
Authorized genericsomapacitan-beco
Regular genericsomapacitan-beco
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Sogroya?
The original
–
–

Brand nameThe maker’s card

Sogroya Savings Offer

Savings card from Novo Nordisk

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a year

The card takes up to $5,000 a year off your co-pay.

Sign up on novocare.com 

In the maker’s words

“If you have commercial insurance, such as insurance you receive through an employer, you may be eligible to pay as little as $0 per year for your supply of Sogroya® (with an annual maximum cap of $5,000).”

From the maker’s offer on novocare.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Sogroya itself, from the same company, sold without the brand name, and usually for less. For now Sogroya is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Sogroya is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

SOGROYA is a human growth hormone analog indicated for:

Pediatric Patients: Treatment of pediatric patients aged 2.5 years and older with:

  • Growth failure due to inadequate secretion of endogenous growth hormone (GH).
  • Short stature born small for gestational age (SGA) and with no catch-up growth by 2 years of age.
  • Growth failure associated with Noonan syndrome (NS).
  • Idiopathic Short Stature (ISS).

Adults: Replacement of endogenous growth hormone in adults with growth hormone deficiency (GHD).

Source: the FDA label for Sogroya (Novo Nordisk), February 25, 2026. Full label on DailyMed 

Good to know